Out of stock for ordering This manual provides clinical practice guidelines for using medications in the medication-assisted treatment of alcohol use disorder. It offers guidance on prescribing acamprosate, disulfiram, oral naltrexone, and extended-release injectable naltrexone. The manual also discusses patient management. Access the literature review. Publication ID SMA13-4380 Publication Date May 2013 Format Guidelines or Manual More like this TIP Series - Treatment Improvement Protocols (TIPS) Download TIP 49 PDF 935.57 KB tip49_litrev.pdf PDF 725.17 KB tip49_lit_review_updates.pdf PDF 270.09 KB Find Related Information Audience Professional Care Providers Series TIP Series - Treatment Improvement Protocols (TIPS) You May Also Be Interested In Advisory: Prescribing Pharmacotherapies for Patients With Alcohol Use Disorder This Advisory, based on TIP 49, Incorporating Alcohol Pharmacotherapies Into Medical Practice, focuses on medication and related treatment decisions made after screening and assessment for AUD, and medically supervised withdrawal, if necessary. Alcohol consumption should not stop abruptly in those patients who have consumed alcohol regularly over a prolonged period of time. This Advisory is meant as an overview of AUD medications to facilitate abstinence. Incorporating Alcohol Pharmacotherapies Into Medical Practice This manual guides counselors in the use of medications to help clients achieve abstinence from alcohol. It describes how the medications work and whom may benefit. It also presents the side effects of three FDA-approved medications: acamprosate, disulfiram, and naltrexone. Identifying Mental Health and Substance Use Problems of Children and Adolescents: A Guide for Child-Serving Organizations This manual offers guidance and tools for identifying mental illness or substance use issues early in children and adolescents in various setting, such as in schools, the juvenile justice and child welfare system, and when receiving primary care. A Guide to Substance Abuse Services for Primary Care Clinicians This manual guides clinicians through stages of primary care for alcohol and substance misuse in adult patients. It discusses warning signs of misuse, screening and follow-up, brief intervention, assessment, treatment models, and legal issues. It includes four screening tools. Incorporating Alcohol Pharmacotherapies Into Medical Practice This manual provides physicians with quick reference information about three FDA-approved medications to help patients achieve abstinence from alcohol: acamprosate, disulfiram, and naltrexone (oral and extended-release). It also includes patient management tips. Medication for the Treatment of Alcohol Use Disorder: A Brief Guide This manual provides guidance on the use of medication-assisted treatment for alcohol use misuse. It summarizes approved medications, screening and assessment, treatment planning, and patient monitoring.